Amit Bardia

907 total citations
34 papers, 533 citations indexed

About

Amit Bardia is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Amit Bardia has authored 34 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Surgery. Recurrent topics in Amit Bardia's work include Advanced Breast Cancer Therapies (11 papers), Cancer Treatment and Pharmacology (8 papers) and Cardiac, Anesthesia and Surgical Outcomes (8 papers). Amit Bardia is often cited by papers focused on Advanced Breast Cancer Therapies (11 papers), Cancer Treatment and Pharmacology (8 papers) and Cardiac, Anesthesia and Surgical Outcomes (8 papers). Amit Bardia collaborates with scholars based in United States, Spain and Germany. Amit Bardia's co-authors include Robert B. Schonberger, Sachin Kheterpal, Nirav Shah, Michael R. Mathis, Michelle T. Vaughn, Patrick J. McCormick, Timur Dubovoy, Karsten Bartels, Amy Shanks and Leif Saager and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and Annals of Oncology.

In The Last Decade

Amit Bardia

31 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amit Bardia United States 11 179 166 158 140 107 34 533
Raoul Schorer Switzerland 11 190 1.1× 182 1.1× 21 0.1× 177 1.3× 98 0.9× 29 489
Wichit Srikureja United States 11 41 0.2× 177 1.1× 77 0.5× 94 0.7× 111 1.0× 28 459
Vladimir Gašparović Croatia 14 41 0.2× 97 0.6× 12 0.1× 130 0.9× 74 0.7× 29 523
Rita Mariotti Italy 14 258 1.4× 193 1.2× 48 0.3× 63 0.5× 25 0.2× 43 681
Fernanda Macedo de Oliveira Neves Brazil 13 59 0.3× 120 0.7× 15 0.1× 49 0.3× 22 0.2× 16 473
Marion Pépin France 10 124 0.7× 84 0.5× 70 0.4× 35 0.3× 19 0.2× 35 418
Joshua D. Waltonen United States 15 22 0.1× 345 2.1× 37 0.2× 168 1.2× 192 1.8× 33 665
Anna Batchelor United Kingdom 7 105 0.6× 210 1.3× 29 0.2× 149 1.1× 23 0.2× 12 552
Dimelza Osorio Spain 9 40 0.2× 103 0.6× 13 0.1× 65 0.5× 55 0.5× 26 355
Eric Grossman United States 12 57 0.3× 288 1.7× 19 0.1× 45 0.3× 34 0.3× 16 431

Countries citing papers authored by Amit Bardia

Since Specialization
Citations

This map shows the geographic impact of Amit Bardia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Bardia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Bardia more than expected).

Fields of papers citing papers by Amit Bardia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Bardia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Bardia. The network helps show where Amit Bardia may publish in the future.

Co-authorship network of co-authors of Amit Bardia

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Bardia. A scholar is included among the top collaborators of Amit Bardia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Bardia. Amit Bardia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stroyakovskiy, Daniil, DA Yardley, Chiun‐Sheng Huang, et al.. (2025). LBA14 Adjuvant ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 5-year outcomes. Annals of Oncology. 36. S1559–S1559.
2.
Fasching, Peter A., Daniil Stroyakovskiy, Denise A. Yardley, et al.. (2024). LBA13 Adjuvant ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in patients (Pts) with HR+/HER2− early breast cancer (EBC): 4-year outcomes from the NATALEE trial. Annals of Oncology. 35. S1207–S1207. 17 indexed citations
3.
Kumar, Nicolas, et al.. (2024). The Year in Electrophysiology: Selected Highlights From 2023. Journal of Cardiothoracic and Vascular Anesthesia. 38(8). 1641–1649. 2 indexed citations
4.
Bardia, Amit, et al.. (2023). Association of adherence to individual components of Society of Thoracic Surgeons cardiac surgery antibiotic guidelines and postoperative infections. Journal of Thoracic and Cardiovascular Surgery. 167(6). 2170–2176.e5. 2 indexed citations
5.
Jiménez, M. Martín, Stephanie Hilz, Alejandro Chibly, et al.. (2023). 413P Characteristics of patients (pts) with previously treated, oestrogen receptor-positive, HER2-negative advanced breast cancer (ER+, HER2– aBC) who had rapid progression (RP) in acelERA BC. Annals of Oncology. 34. S356–S357. 1 indexed citations
6.
Wahl, Tyler S., et al.. (2022). Alterations in Pre/Post Oxygenator Flows Due to Fibrin Deposition in the CardioHelp System—A Case Report. Journal of ExtraCorporeal Technology. 54(3). 239–241.
7.
Bardia, Amit, Ranjit Deshpande, George Michel, et al.. (2022). Demonstration and Performance Evaluation of Two Novel Algorithms for Removing Artifacts From Automated Intraoperative Temperature Data Sets: Multicenter, Observational, Retrospective Study. SHILAP Revista de lepidopterología. 5(1). e37174–e37174. 1 indexed citations
11.
Schonberger, Robert B., Feng Dai, George Michel, et al.. (2022). Association of propofol induction dose and severe pre-incision hypotension among surgical patients over age 65. Journal of Clinical Anesthesia. 80. 110846–110846. 25 indexed citations
12.
Rugo, H. S., Patrick Schmid, Sara M. Tolaney, et al.. (2022). 1553O Health-related quality of life (HRQoL) in the phase III TROPiCS-02 trial of sacituzumab govitecan (SG) vs chemotherapy in HR+/HER2- metastatic breast cancer (MBC). Annals of Oncology. 33. S1258–S1258. 4 indexed citations
14.
Mazzeffi, Michael, Vidya K. Rao, Jeffrey M. Dodd‐o, et al.. (2021). Intraoperative Management of Adult Patients on Extracorporeal Membrane Oxygenation: an Expert Consensus Statement From the Society of Cardiovascular Anesthesiologists—Part I, Technical Aspects of Extracorporeal Membrane Oxygenation. Journal of Cardiothoracic and Vascular Anesthesia. 35(12). 3496–3512. 2 indexed citations
15.
Kheterpal, Sachin, Michelle T. Vaughn, Timur Dubovoy, et al.. (2020). Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER). Anesthesiology. 132(6). 1371–1381. 171 indexed citations
16.
Schonberger, Robert B., Yuemei Zhang, Feng Dai, et al.. (2020). Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients. Preventive Medicine Reports. 18. 101085–101085. 6 indexed citations
17.
Bardia, Amit, et al.. (2020). Anesthesia at the Edge of Life. Anesthesiology Clinics. 38(1). 19–33. 5 indexed citations
19.
Bardia, Amit, et al.. (2019). Preoperative chlorhexidine mouthwash to reduce pneumonia after cardiac surgery: A systematic review and meta-analysis. Journal of Thoracic and Cardiovascular Surgery. 158(4). 1094–1100. 33 indexed citations
20.
Bardia, Amit, et al.. (2018). Sodium-glucose cotransporter-2 inhibitors. Current Opinion in Anaesthesiology. 32(1). 80–85. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026